Role of periodically rotated overlapping parallel lines with enhanced reconstruction diffusion-weighted imaging in correcting distortion and evaluating head and neck masses using 3 T MRI.

AIM To investigate the role of periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) diffusion-weighted imaging (DWI) in correcting distortion and evaluating head and neck masses. MATERIALS AND METHODS Both PROPELLER and echo planar diffusion weighted imaging (EP-DWI) with different b values were performed using 3 T MRI in 50 patients with solid masses of the head and neck. Distortion severity of 50 masses with both DWI techniques and different b values was qualitatively scored and compared. The apparent diffusion coefficient (ADC) values of the 45 masses, in which the distortion scores with both DWI techniques were ≥2, were measured and calculated. The mean ADC value of each DWI sequence between benign and malignant masses was compared. RESULTS The mean distortion scores of PROPELLER DWIs were significantly higher than EP-DWIs (3.87 versus 1.96, and 3.88 versus 2.00, with b values of 1000 and 500 s/mm(2), respectively, p < 0.001), indicating distortion of the mass on PROPELLER DWIs was much less than that on EP-DWIs. With either PROPELLER or EP-DWI, the mean ADC value of 24 malignant tumours was significantly lower than that of 21 benign masses (p < 0.001). CONCLUSION Severe distortion of head and neck masses can be reduced significantly using PROPELLER DWI. Moreover, PROPELLER DWI plays an important role in differentiating malignancies from benign masses.

[1]  F. Yamasaki,et al.  Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions. , 2010, European journal of radiology.

[2]  T. Kurabayashi,et al.  Salivary glands and lesions: evaluation of apparent diffusion coefficients with split-echo diffusion-weighted MR imaging--initial results. , 2001, Radiology.

[3]  J. Pipe Motion correction with PROPELLER MRI: Application to head motion and free‐breathing cardiac imaging , 1999, Magnetic resonance in medicine.

[4]  R. Gillies,et al.  Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. , 1999, Neoplasia.

[5]  A. Razek,et al.  Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes , 2007, American Journal of Neuroradiology.

[6]  Bradford A Moffat,et al.  An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. , 2007, Cancer research.

[7]  Chun-Jung Juan,et al.  Salivary glands: echo-planar versus PROPELLER Diffusion-weighted MR imaging for assessment of ADCs. , 2009, Radiology.

[8]  Bradford A Moffat,et al.  Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy , 2007, Clinical Cancer Research.

[9]  J. Vallée,et al.  3T MR Imaging of Postoperative Recurrent Middle Ear Cholesteatomas: Value of Periodically Rotated Overlapping Parallel Lines with Enhanced Reconstruction Diffusion-Weighted MR Imaging , 2008, American Journal of Neuroradiology.

[10]  R. Hermans,et al.  Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma , 2010, European Radiology.

[11]  R. Kauppinen,et al.  Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. , 1998, Cancer gene therapy.

[12]  G. Weinstein,et al.  Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck , 2009, Clinical Cancer Research.

[13]  Diffusion-Weighted Imaging in Patients With Acute Brain Ischemia at 3 T: Current Possibilities and Future Perspectives Comparing Conventional Echoplanar Diffusion-Weighted Imaging and Fast Spin Echo Diffusion-Weighted Imaging Sequences Using BLADE (PROPELLER) , 2009, Investigative radiology.

[14]  Ann D. King,et al.  Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response , 2010, European Radiology.

[15]  A. King,et al.  Diffusion-weighted MR imaging in the head and neck. , 2012, Radiology.

[16]  Sandra Nuyts,et al.  Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings. , 2007, International journal of radiation oncology, biology, physics.

[17]  Bradford A Moffat,et al.  Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Kurabayashi,et al.  Tissue characterization of head and neck lesions using diffusion-weighted MR imaging with SPLICE. , 2009, European journal of radiology.

[19]  R. de Bree,et al.  Diffusion-Weighted MR Imaging in Head and Neck Cancer: Comparison between Half-Fourier Acquired Single-Shot Turbo Spin-Echo and EPI Techniques , 2012, American Journal of Neuroradiology.

[20]  J. Casselman,et al.  Detection of Postoperative Residual Cholesteatoma With Non-Echo-Planar Diffusion-Weighted Magnetic Resonance Imaging , 2008, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[21]  T. Chenevert,et al.  Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. , 2008, Translational oncology.

[22]  J. M. Taylor,et al.  Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.

[23]  James G Pipe,et al.  Multishot diffusion‐weighted FSE using PROPELLER MRI , 2002, Magnetic resonance in medicine.